Luther King Capital Management (LKCM) Portfolio holdings
AUM
$23B
1-Year Return
15.96%
This Quarter Return
+6.97%
1 Year Return
+15.96%
3 Year Return
+72.77%
5 Year Return
+138.1%
10 Year Return
+369.43%
AUM
$23.3B
AUM Growth
+$1.11B
(+5%)
Cap. Flow
-$327M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
33.98%
Holding
627
New
24
Increased
222
Reduced
186
Closed
23
Top Buys
| 1 |
Wheaton Precious Metals
WPM
|
+$29.8M |
| 2 |
Keurig Dr Pepper
KDP
|
+$28.8M |
| 3 |
Linde
LIN
|
+$27.6M |
| 4 |
IDEX
IEX
|
+$22.2M |
| 5 |
Netflix
NFLX
|
+$16.8M |
Top Sells
| 1 |
Parker-Hannifin
PH
|
+$70.2M |
| 2 |
Microsoft
MSFT
|
+$65.3M |
| 3 |
Charles River Laboratories
CRL
|
+$49.8M |
| 4 |
Nike
NKE
|
+$34.9M |
| 5 |
PepsiCo
PEP
|
+$34.7M |
Sector Composition
| 1 | Technology | 27.18% |
| 2 | Industrials | 20.44% |
| 3 | Healthcare | 12.69% |
| 4 | Financials | 9.13% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
MetLife
MET
$52.7B
| $2.48M | 0.01% |
30,068
+629
| +2% | +$51.9K |
|
302
Kadant
KAI
$3.72B
| $2.42M | 0.01% |
7,156
+48
| +0.7% | +$16.2K |
|
303
Idexx Laboratories
IDXX
$52.5B
| $2.37M | 0.01% |
4,697
-14
| -0.3% | -$7.07K |
|
304
FIVE9
FIVN
$2.04B
| $2.36M | 0.01% |
82,166
+35,413
| +76% | +$1.02M |
|
305
LKQ Corp
LKQ
$8.31B
| $2.26M | 0.01% |
56,638
-7,817
| -12% | -$312K |
|
306
Exact Sciences
EXAS
$10.5B
| $2.23M | 0.01% |
32,749
+54
| +0.2% | +$3.68K |
|
307
Colliers International
CIGI
$8.45B
| $2.22M | 0.01% |
14,639
+178
| +1% | +$27K |
|
308
Amphenol
APH
$143B
| $2.22M | 0.01% |
34,034
+2
| +0% | +$130 |
|
309
Builders FirstSource
BLDR
$15.5B
| $2.21M | 0.01% |
11,416
+149
| +1% | +$28.9K |
|
310
CRH
CRH
$74.3B
| $2.16M | 0.01% |
23,295
+35
| +0.2% | +$3.25K |
|
311
KLA
KLAC
$121B
| $2.14M | 0.01% |
2,761
+176
| +7% | +$136K |
|
312
TE Connectivity
TEL
$61.7B
| $2.1M | 0.01% |
13,923
+288
| +2% | +$43.5K |
|
313
Main Street Capital
MAIN
$5.9B
| $2.09M | 0.01% |
41,710
| – | – |
|
314
Chubb
CB
$110B
| $2.06M | 0.01% |
7,139
+160
| +2% | +$46.1K |
|
315
Middleby
MIDD
$7.03B
| $2.05M | 0.01% |
14,700
| – | – |
|
316
Iron Mountain
IRM
$28.6B
| $2.05M | 0.01% |
17,211
-304
| -2% | -$36.1K |
|
317
Novo Nordisk
NVO
$241B
| $2.04M | 0.01% |
17,172
-10,999
| -39% | -$1.31M |
|
318
Intel
INTC
$114B
| $2.03M | 0.01% |
86,713
-53,680
| -38% | -$1.26M |
|
319
BioMarin Pharmaceuticals
BMRN
$10.7B
| $2.03M | 0.01% |
+28,840
| New | +$2.03M |
|
320
SPDR Gold Trust
GLD
$115B
| – | – |
0
| – | -$1.76M |
|
321
iShares Core High Dividend ETF
HDV
$11.5B
| – | – |
0
| – | -$1.98M |
|
322
Target
TGT
$41.3B
| $1.94M | 0.01% |
12,462
-983
| -7% | -$153K |
|
323
Agilent Technologies
A
$35.8B
| $1.94M | 0.01% |
13,054
-62
| -0.5% | -$9.21K |
|
324
Norfolk Southern
NSC
$61.3B
| $1.94M | 0.01% |
7,789
-371
| -5% | -$92.2K |
|
325
Corning
GLW
$62B
| $1.92M | 0.01% |
42,488
+13,037
| +44% | +$589K |
|